About Pharvaris
Pioneering science for patient choice
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Zug
- Founded
- 2015
- Company type
- Public Company
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists for bradykinin mediated diseases. Harnessing established science, the company aims to deliver oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care.
Our legacy, scientific expertise, and values drive our passion as we aspire to provide choice to people living with bradykinin-mediated diseases.
Specialties
- Medicinal Chemistry
- Hereditary Angioedema
- Drug Discovery
- Drug Development
- Biotechnology
- and Pharmaceuticals
Company locations
Grafenauweg 8, Zug, 6300, CH
J.H. Oortweg, Leiden, South Holland 2333, NL
303 Wyman St, Suite 300, Waltham, MA 02451, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biotechnology
- Life Science
- Pharmaceutical
On LinkedIn
- Followers
- 11,574
- People linked to this company
- 163
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
848,487,335 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.